| pubmed-article:1757943 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:1757943 | lifeskim:mentions | umls-concept:C0553662 | lld:lifeskim |
| pubmed-article:1757943 | lifeskim:mentions | umls-concept:C0035647 | lld:lifeskim |
| pubmed-article:1757943 | lifeskim:mentions | umls-concept:C0205127 | lld:lifeskim |
| pubmed-article:1757943 | lifeskim:mentions | umls-concept:C0022073 | lld:lifeskim |
| pubmed-article:1757943 | lifeskim:mentions | umls-concept:C0019721 | lld:lifeskim |
| pubmed-article:1757943 | lifeskim:mentions | umls-concept:C0332281 | lld:lifeskim |
| pubmed-article:1757943 | lifeskim:mentions | umls-concept:C0936012 | lld:lifeskim |
| pubmed-article:1757943 | pubmed:issue | 9 | lld:pubmed |
| pubmed-article:1757943 | pubmed:dateCreated | 1992-2-6 | lld:pubmed |
| pubmed-article:1757943 | pubmed:abstractText | The risk of iridocyclitis in children with early onset pauciarticular juvenile rheumatoid arthritis (EOPA-JRA) has been shown to be associated with certain HLA haplotypes. Our report contains an actuarial analysis, using one-year intervals, of 161 subjects and estimates haplotype specific risks. Individuals who possess the major susceptibility haplotype HLA-DR5 (11) developed eye disease earlier and with a greater frequency than did those with the protective HLA-DR1 haplotype. Highly significant differences were found between the resulting life-table curves for HLA-DR5 and HLA-DR1 positive subjects (p = 0.00003). These time oriented risk estimates may aid clinicians in determining more precisely the probability of iridocyclitis throughout the course of the disease in children with EOPA-JRA. | lld:pubmed |
| pubmed-article:1757943 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1757943 | pubmed:language | eng | lld:pubmed |
| pubmed-article:1757943 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1757943 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:1757943 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:1757943 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:1757943 | pubmed:month | Sep | lld:pubmed |
| pubmed-article:1757943 | pubmed:issn | 0315-162X | lld:pubmed |
| pubmed-article:1757943 | pubmed:author | pubmed-author:TaylorJJ | lld:pubmed |
| pubmed-article:1757943 | pubmed:author | pubmed-author:GinsbergJJ | lld:pubmed |
| pubmed-article:1757943 | pubmed:author | pubmed-author:LevinsonJ EJE | lld:pubmed |
| pubmed-article:1757943 | pubmed:author | pubmed-author:BurkeM JMJ | lld:pubmed |
| pubmed-article:1757943 | pubmed:author | pubmed-author:LovellD JDJ | lld:pubmed |
| pubmed-article:1757943 | pubmed:author | pubmed-author:GlassD NDN | lld:pubmed |
| pubmed-article:1757943 | pubmed:author | pubmed-author:GianniniE HEH | lld:pubmed |
| pubmed-article:1757943 | pubmed:author | pubmed-author:Van... | lld:pubmed |
| pubmed-article:1757943 | pubmed:author | pubmed-author:PassoM HMH | lld:pubmed |
| pubmed-article:1757943 | pubmed:author | pubmed-author:MalagonC NCN | lld:pubmed |
| pubmed-article:1757943 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:1757943 | pubmed:volume | 18 | lld:pubmed |
| pubmed-article:1757943 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:1757943 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:1757943 | pubmed:pagination | 1394-7 | lld:pubmed |
| pubmed-article:1757943 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:meshHeading | pubmed-meshheading:1757943-... | lld:pubmed |
| pubmed-article:1757943 | pubmed:year | 1991 | lld:pubmed |
| pubmed-article:1757943 | pubmed:articleTitle | Longitudinal analysis of HLA associated risks for iridocyclitis in juvenile rheumatoid arthritis. | lld:pubmed |
| pubmed-article:1757943 | pubmed:affiliation | Division of Rheumatology, Children's Hospital Medical Center, Cincinnati, OH 45229. | lld:pubmed |
| pubmed-article:1757943 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:1757943 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| pubmed-article:1757943 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:1757943 | lld:pubmed |
